Sector News

Oatly changing growth strategy

August 7, 2022
Food & Drink

Oatly Group AB is tapping the brakes on its growth strategy, downshifting from a breakneck pace to add production as rapidly as possible to a more moderate approach. The rationale behind the change are macroeconomic issues like high inflation in Europe and a slowness in China as various regions of the country have gone into and come out of COVID-19 lockdowns.

The oat-based dairy alternative manufacturer lowered its 2022 capital expenditure forecast from between $400 million to $500 million to a range of $220 million to $240 million. Toni Petersson, chief executive officer, said during an Aug. 2 conference call with analysts that the change represents a tactical shift to balance speed to market with supply chain execution and cash flow management.

“We will continue to prioritize our investments in the regions where our fill rate caps are the highest and, therefore, where need for additional production volumes is the most pressing — Americas and Asia,” he said.

The company raised its sales guidance to a range of $800 million to $830 million, up 24% to 29% over full-year 2021 results. Foreign currency exchange rates account for $35 million of the revision, according to the company.

“The update to our guidance range is driven by our assessment of the overall macro-environment,” said Christian Hanke, chief financial officer. “Although our second-quarter performance was strong on a constant currency basis and in line with the full-year guidance we reiterated at our first-quarter earnings, our outlook for the second half reflects a range of outcomes where there are several external factors that could impact our business performance.”

Mr. Hanke said Oatly’s European business is being affected by rising inflation and ripple effects from the war in Ukraine, and that prompted the more cautious approach.

“More specifically, it is impacting the speed at which we are able to expand our distribution footprint in 2022, particularly in foodservice and new markets,” he said.

During the second quarter ended June 30, Oatly recorded a loss of $72 million, an increase over the loss of $59.1 million the year prior.

Quarterly sales rose to $178 million from $146 million the previous year.

“Our velocity has remained stable so far despite the macro-dynamics and continues to be at similar levels as prior quarters,” Mr. Petersson said. “Building on this performance and market leadership, we see significant growth opportunities across our channels with product innovation and in new markets.”

In the EMEA (European, Middle East and Africa) business unit, Oatly’s largest, sales rose 5% to $82.5 million. A foreign currency headwind of $10.6 million pressured results, but the unit experienced growth at foodservice and in retail for its oat-based beverage products, the company said.

In the Americas, sales rose 25% to $51.8 million. Additional production from a new processing plant in Ogden, Utah, drove the sales growth. Approximately 55% of the Americas revenue was from the retail channel in the second quarter of 2022, according to the company.

In Asia, sales were $43.7 million during the quarter, up from $26.3 million the year before. Oatly said COVID-19 lockdowns during the quarter hindered the business unit’s results.

One issue facing Oatly is the relative newness of the oat-based dairy alternative category. Unlike the manufacturers of more traditional food and beverage products, the category does not have a long record of elasticities during different economic periods. Mr. Petersson emphasized during the call that plant-based consumers are “sticky” and not shifting away from the category.

“This is not about demand,” he said. “This is about the pace of growth and … the timing of how fast you can recruit consumers into the space.”

By Keith Nunes


comments closed

Related News

February 4, 2023

Unilever names FrieslandCampina’s Hein Schumacher as next CEO

Food & Drink

Schumacher will replace Alan Jope, who announced his decision to retire last September, less than a year after a failed attempt by Unilever to buy GlaxoSmithKline’s consumer healthcare business and just months after activist investor Nelson Peltz joined the company’s board.

February 4, 2023

Tetra Pak execs flag plant-based ice cream development hurdles as indulgent offerings expand

Food & Drink

Globally, plant-based ice creams have doubled their share of the market over the last five years, according to Tetra Pack. Pea protein and coconut milk are leading the way, but Tetra Pak cites data showing that oat-based ice cream launches have doubled in the previous year.

February 4, 2023

Examining the meaning of eco-labels: Is it time for mandated methodology?

Food & Drink

A myriad of so-called eco-labels are being rolled out across various F&B products, but with no gold standard or strict rules governing precisely what the logos mean and what methodology is behind them, concerns are growing that they will confuse consumers and ultimately be counterproductive.

How can we help you?

We're easy to reach